LIK066
|
|
LIK066 Eigenschaften
- Siedepunkt:
- 629.9±55.0 °C(Predicted)
- Dichte
- 1.333±0.06 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- pka
- 13.34±0.70(Predicted)
- Aggregatzustand
- Solid
- Farbe
- White to off-white
- Wasserl?slichkeit
- Water : 2 mg/mL (4.80 mM)
Sicherheit
LIK066 Chemische Eigenschaften,Einsatz,Produktion Methoden
LIK066 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
2-bromo-5-iodobenzoyl chloride
1291094-64-8
(3R,4S,5S,6R)-2-(4-bromo-3-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)meth yl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
6-(2-Bromo-5-iodobenzyl)-2,3-dihydrobenzo[b][1,4]dioxine
2-BROMO-5-IODOBENZOIC ACID
Downstream Produkte
LIK066 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 32)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 |
ivan@atkchemical.com | China | 32957 | 60 |
BOC Sciences | +1-631-485-4226 |
inquiry@bocsci.com | United States | 19553 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 |
marketing@targetmol.com | United States | 32161 | 58 |
HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 |
sales@hzclap.com | CHINA | 6312 | 58 |
InvivoChem | +1-708-310-1919 +1-13798911105 |
sales@invivochem.cn | United States | 6391 | 58 |
Nanjing Doge Biomedical Technology Co., Ltd | +86-25-58227606 +86-15305155328 |
sales@dogechemical.com | China | 4128 | 58 |
TargetMol Chemicals Inc. | |
support@targetmol.com | United States | 38631 | 58 |
LEAPCHEM CO., LTD. | +86-852-30606658 |
market18@leapchem.com | China | 43340 | 58 |
Wuhan Jingkang en Biomedical Technology Co., Ltd | +8613720134139 |
orders@jknbiochem.com | China | 5221 | 58 |
Shanghai Topbiochem Technology Co., Ltd | 021-58170097 |
info@topbiochem.com | China | 9458 | 58 |
- LIK066
- Licogliflozin (LIK066)
- Licogliflozin
- (2S,3R,4R,5S,6R)-2-[3-(2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YLMETHYL)-4-ETHYL-PHENYL]-6-HYDROXYMETHYL-TETR
- (2S,3R,4R,5S,6R)-2-[3-(2,3-dihydro-benzo[1,4]dioxin-6-ylmethyl)-4-ethyl-phenyl]-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol
- D-Glucitol, 1,5-anhydro-1-C-[3-[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]-4-ethylphenyl]-, (1S)-
- SGLT,LIK 066,LIK-066,Licogliflozin,inhibit,Sodium-dependent glucose cotransporters,Inhibitor
- (2S,3R,4R,5S,6R)-2-(3-((2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)methyl)-4-ethylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
- 1291094-73-9